KROS
Price
$14.69
Change
+$0.25 (+1.73%)
Updated
Jul 14, 11:53 AM (EDT)
Capitalization
586.49M
17 days until earnings call
MRNA
Price
$33.15
Change
-$0.49 (-1.46%)
Updated
Jul 14, 02:17 PM (EDT)
Capitalization
13.01B
17 days until earnings call
Interact to see
Advertisement

KROS vs MRNA

Header iconKROS vs MRNA Comparison
Open Charts KROS vs MRNABanner chart's image
Keros Therapeutics
Price$14.69
Change+$0.25 (+1.73%)
Volume$400
Capitalization586.49M
Moderna
Price$33.15
Change-$0.49 (-1.46%)
Volume$3.22K
Capitalization13.01B
KROS vs MRNA Comparison Chart in %
Loading...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KROS vs. MRNA commentary
Jul 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KROS is a Hold and MRNA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2025
Stock price -- (KROS: $14.44 vs. MRNA: $33.64)
Brand notoriety: KROS: Not notable vs. MRNA: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KROS: 56% vs. MRNA: 59%
Market capitalization -- KROS: $586.49M vs. MRNA: $13.01B
KROS [@Biotechnology] is valued at $586.49M. MRNA’s [@Biotechnology] market capitalization is $13.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $318.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KROS’s FA Score shows that 1 FA rating(s) are green whileMRNA’s FA Score has 1 green FA rating(s).

  • KROS’s FA Score: 1 green, 4 red.
  • MRNA’s FA Score: 1 green, 4 red.
According to our system of comparison, MRNA is a better buy in the long-term than KROS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KROS’s TA Score shows that 4 TA indicator(s) are bullish while MRNA’s TA Score has 5 bullish TA indicator(s).

  • KROS’s TA Score: 4 bullish, 6 bearish.
  • MRNA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MRNA is a better buy in the short-term than KROS.

Price Growth

KROS (@Biotechnology) experienced а +7.36% price change this week, while MRNA (@Biotechnology) price change was +10.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +13.15%. For the same industry, the average monthly price growth was +23.60%, and the average quarterly price growth was +32.61%.

Reported Earning Dates

KROS is expected to report earnings on Oct 30, 2025.

MRNA is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+13.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRNA($13B) has a higher market cap than KROS($586M). KROS YTD gains are higher at: -8.781 vs. MRNA (-19.096). KROS has higher annual earnings (EBITDA): 14.8M vs. MRNA (-3.2B). MRNA has more cash in the bank: 5.98B vs. KROS (721M). KROS has less debt than MRNA: KROS (18.4M) vs MRNA (745M). MRNA has higher revenues than KROS: MRNA (3.14B) vs KROS (215M).
KROSMRNAKROS / MRNA
Capitalization586M13B5%
EBITDA14.8M-3.2B-0%
Gain YTD-8.781-19.09646%
P/E RatioN/AN/A-
Revenue215M3.14B7%
Total Cash721M5.98B12%
Total Debt18.4M745M2%
FUNDAMENTALS RATINGS
MRNA: Fundamental Ratings
MRNA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KROSMRNA
RSI
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 4 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
81%
Momentum
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
84%
MACD
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 15 days ago
82%
Bearish Trend 27 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
77%
Aroon
ODDS (%)
Bearish Trend 4 days ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEATX51.920.01
+0.02%
Fidelity Advisor Emerging Asia M
MNDFX8.52-0.05
-0.58%
Manning & Napier Disciplined Value I
JIGTX32.48-0.26
-0.79%
JHancock International Growth R6
TCMSX41.38-0.36
-0.86%
Voya Small Cap Growth I
RYSVX206.02-1.96
-0.94%
Rydex S&P SmallCap 600 Pure Value A